Dexus Property Group has announced that it has secured Roche (Pharmaceuticals) Australia for a long term lease across 4,418 square metres at 30 The Bond, Sydney.
Kevin George, Executive General Manager, Office & Industrial said: “As a result of this lease, Roche will take up around 25% of the space at 30 The Bond previously occupied by Lend Lease. We have been able to build on our existing relationship with Roche and capture the flight to quality that is underway in the Sydney office market.”
Roche will be relocating its head office from the Northern Beaches and is excited about the move to the Sydney CBD.
Roche (Pharmaceuticals) Australia Managing Director, Svend Peterson said: "The new CBD location will help Roche create a modern, vibrant and collaborative workspace and improve accessibility and connectivity with a wide range of stakeholders. We anticipate that culture change will occur as a result of the location changes and our increased focus on greater flexibility and collaboration."Dexus has negotiated a settlement with Lend Lease to terminate its lease obligations relating to the office space they occupied at 30 The Bond. In addition to the Roche lease, Dexus is in negotiations with several parties to lease the remainder of the space.
30 The Bond is an award-winning contemporary nine level office building located in Sydney's newest business, retail and dining precinct - Barangaroo. The A Grade building offers some of the largest floor plates in Sydney providing the best in workspace efficiency, integration and interaction. The lobby features internal stairs, glass lifts, and suspended meeting rooms with large break out spaces.
Dexus, Australia’s biggest landlord, this week posted a $1.26 billion statutory net profit for the 2016 financial year, double that of 2015 due to $814.4 million in revaluations. The company had a record year of office leasing activity with 385 leasing deals undertaken across 269,866 square metres.
Image: PTW Architects